- 28 February 2022
- Patient action plans
Action plan: Low-dose methotrexate to treat plaque psoriasis/用于治疗斑块状银屑病的低剂量甲氨蝶呤 (Chinese / 普通话)
- 28 February 2022
- Patient action plans
Corporate documents
Annual reports, budgets, corporate plans, reports
Clinical resources
Fact sheets, action plans, brochures, guidelines, and more for health professionals and consumers
Multimedia
Videos, podcasts, conference recordings, images and Infographics
Filter
Sort by:
Action plan: Low-dose methotrexate to treat plaque psoriasis/用于治疗斑块状银屑病的低剂量甲氨蝶呤 (Chinese / 普通话)
Action plan: Low-dose methotrexate for Crohn's disease/用于克罗恩病的低剂量甲氨蝶呤 (Chinese / 普通话)
- 28 February 2022
- Patient action plans
Action plan: Low-dose methotrexate for Crohn's disease/用于克罗恩病的低剂量甲氨蝶呤 (Chinese / 普通话)
- 28 February 2022
- Patient action plans
Action plan: Managing your arthritis flare/控制您的关节炎发作 (Chinese / 普通话)
- 28 February 2022
- Patient action plans
Action plan: Managing your arthritis flare/控制您的关节炎发作 (Chinese / 普通话)
- 28 February 2022
- Patient action plans
Action plan: Thiopurines for inflammatory bowel disease/治疗炎症性肠病的硫嘌呤 (Chinese / 普通话)
- 28 February 2022
- Patient action plans
Action plan: Thiopurines for inflammatory bowel disease/治疗炎症性肠病的硫嘌呤 (Chinese / 普通话)
- 28 February 2022
- Patient action plans
Action plan: Low-dose methotrexate for rheumatoid arthritis and psoriatic arthritis/用于治疗类风湿性关节炎和银屑病关节炎的低剂量 甲氨蝶呤 (Chinese / 普通话)
- 28 February 2022
- Patient action plans
Action plan: Low-dose methotrexate for rheumatoid arthritis and psoriatic arthritis/用于治疗类风湿性关节炎和银屑病关节炎的低剂量 甲氨蝶呤 (Chinese / 普通话)
- 28 February 2022
- Patient action plans
Episode 39: COVID treatment update: Answers to what HPs are asking
- 24 March 2022
- Podcasts
Episode 39: COVID treatment update: Answers to what HPs are asking
- 24 March 2022
- Podcasts
In this episode, NPS MedicineWise medical advisor Dr Caroline West speaks with Prof Sarah Hilmer and Prof Josh Davis, members of the National COVID-19 Clinical Evidence Taskforce Guidelines Leadership Group. They give an update on the new antiviral treatments now available and answer some frequently asked COVID management questions.
Further reading
NPS MedicineWise www.nps.org.au/coronavirus/faqs-covid-19-antivirals-in-racfs
National COVID-19 Clinical Evidence Taskforce www.covid19evidence.net.au
Liverpool University Drug Interaction www.hiv-druginteractions.org/checker
Episode 38: New oral antiviral COVID medications: What HPs need to know
- 10 February 2022
- Podcasts
Episode 38: New oral antiviral COVID medications: What HPs need to know
- 10 February 2022
- Podcasts
In this episode, NPS MedicineWise medical advisor Dr Caroline West speaks to Dr Kate Annear, NPS MedicineWise medical advisor and Associate Professor Charlotte Hespe, GP, head of General Practice at Notre Dame University, and chair of the New South Wales ACT Faculty of the RACGP discuss the new oral antiviral COVID medications that have been provisionally approved for use.
Further reading
NPS MedicineWise https://www.nps.org.au/coronavirus/faqs-covid-19-antivirals-in-racfs
Episode 37: Fostering shared decision-making in primary care
- 10 February 2022
- Podcasts
Episode 37: Fostering shared decision-making in primary care
- 10 February 2022
- Podcasts
In this episode, NPS MedicineWise medical advisor Dr Caroline West speaks with Dr Karen Price, RACGP President on how being involved with shared decision-making can make a difference.
Further reading
Choosing Wisely: https://www.choosingwisely.org.au/resources/consumers-and-carers/5questions
Choosing Wisely: https://www.choosingwisely.org.au/translated-resources
How a medicines review in your home can help you get the most from your medicines
- 1 October 2021
- Fact sheets and FAQs
How a medicines review in your home can help you get the most from your medicines
- 1 October 2021
- Fact sheets and FAQs
How a medicines review in your home can help you get the most from your medicines
- 1 October 2021
- Fact sheets and FAQs
How a medicines review in your home can help you get the most from your medicines
- 1 October 2021
- Fact sheets and FAQs